EPO and hepcidin plasma concentrations in blood donors and β-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.
作者信息
Schotten Nienke, Laarakkers Coby M M, Roelofs Rian W, Origa Raffaella, van Kraaij Marian G J, Swinkels Dorine W
机构信息
Department Donor Studies, Sanquin Research, Amsterdam, the Netherlands.
Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud university medical center, Nijmegen, the Netherlands.
出版信息
Am J Hematol. 2017 Mar;92(3):E29-E31. doi: 10.1002/ajh.24636.
Abstract
摘要
相似文献
1
EPO and hepcidin plasma concentrations in blood donors and β-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.献血者和中间型β地中海贫血患者血浆中促红细胞生成素（EPO）和铁调素的浓度与商业检测的血浆促红细胞生成素红细胞铁结合蛋白（ERFE）浓度无关。
Am J Hematol. 2017 Mar;92(3):E29-E31. doi: 10.1002/ajh.24636.
2
Immunoassay for human serum erythroferrone.人血清红细胞铁调素免疫测定法
Blood. 2017 Sep 7;130(10):1243-1246. doi: 10.1182/blood-2017-04-777987. Epub 2017 Jul 24.
3
Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.红细胞生成素，新的铁调节因子：评估其在埃及β地中海贫血患者中的水平。
Ann Hematol. 2020 Jan;99(1):31-39. doi: 10.1007/s00277-019-03882-w. Epub 2019 Dec 13.
4
Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.马拉松跑引起的促红细胞生成素-红细胞生成素铁调节蛋白-铁调素轴的变化是铁依赖性的。
Int J Environ Res Public Health. 2020 Apr 17;17(8):2781. doi: 10.3390/ijerph17082781.
5
Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.早期乳腺癌患者的血浆铁调素：与白细胞介素-6、促红细胞生成素和促红细胞生成素铁蛋白无关。
Expert Rev Proteomics. 2015;12(6):695-701. doi: 10.1586/14789450.2015.1099436. Epub 2015 Oct 23.
6
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?促红细胞生成素-红细胞生成素铁调节蛋白-铁调素轴在人类新生儿中是否完整？
Blood Cells Mol Dis. 2021 May;88:102536. doi: 10.1016/j.bcmd.2021.102536. Epub 2021 Jan 6.
7
Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias.依赖输血和不依赖输血的地中海贫血症中的红细胞生成和铁参数。
J Pediatr Hematol Oncol. 2021 Jul 1;43(5):186-192. doi: 10.1097/MPH.0000000000002046.
8
Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients.评估伊拉克依赖输血的β-地中海贫血重型患者的红细胞生成素、铁调素和铁过载状态。
Hemoglobin. 2020 Jul;44(4):272-277. doi: 10.1080/03630269.2020.1794888. Epub 2020 Jul 27.
9
Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.非输血依赖型地中海贫血伴髓外造血患者的红细胞生成和铁稳态。
Biomed Res Int. 2019 Jan 30;2019:4504302. doi: 10.1155/2019/4504302. eCollection 2019.
10
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion.抗 TNF 治疗通过调节原血红素肽改善炎症性肠病的铁供应，其作用方式与 IL-6 有关。
Can J Gastroenterol Hepatol. 2017;2017:6843976. doi: 10.1155/2017/6843976. Epub 2017 Jan 16.
引用本文的文献
1
A randomized placebo-controlled clinical trial of oral green tea epigallocatechin 3-gallate on erythropoiesis and oxidative stress in transfusion-dependent β-thalassemia patients.一项关于口服表没食子儿茶素没食子酸酯对依赖输血的β地中海贫血患者红细胞生成和氧化应激影响的随机安慰剂对照临床试验。
Front Mol Biosci. 2024 Jan 24;10:1248742. doi: 10.3389/fmolb.2023.1248742. eCollection 2023.
2
Autologous Blood Doping Induced Changes in Red Blood Cell Rheologic Parameters, RBC Age Distribution, and Performance.自体血兴奋剂诱导的红细胞流变学参数、红细胞年龄分布及运动表现的变化
Biology (Basel). 2022 Apr 23;11(5):647. doi: 10.3390/biology11050647.
3
Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia.遗传性溶血性贫血患者中促红细胞生成素、成纤维细胞生长因子 23 和红细胞生成素之间的相互作用。
Blood Adv. 2020 Apr 28;4(8):1678-1682. doi: 10.1182/bloodadvances.2020001595.
4
Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women.在缺铁性贫血的女性中，隔日补充比连续日补充能更有效地吸收补充剂中的铁。
Haematologica. 2020 May;105(5):1232-1239. doi: 10.3324/haematol.2019.220830. Epub 2019 Aug 14.
5
The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research.红细胞祖细胞中的促红细胞生成素-成纤维细胞生长因子23信号通路：开启一个新的研究领域。
Front Physiol. 2019 Mar 26;10:304. doi: 10.3389/fphys.2019.00304. eCollection 2019.
6
Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.非输血依赖型地中海贫血伴髓外造血患者的红细胞生成和铁稳态。
Biomed Res Int. 2019 Jan 30;2019:4504302. doi: 10.1155/2019/4504302. eCollection 2019.
7
Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.地中海贫血患者的红细胞生成和铁代谢失衡。
Int J Med Sci. 2019 Jan 1;16(2):302-310. doi: 10.7150/ijms.27829. eCollection 2019.
本文引用的文献
1
The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism.56天的献血间隔需要延长至180天，以便全血捐献者从铁代谢变化中恢复过来。
Blood. 2016 Oct 27;128(17):2185-2188. doi: 10.1182/blood-2016-04-709451. Epub 2016 Sep 1.
2
Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.红细胞生成素与红细胞生成及铁代谢生物标志物之间的关联，以及血液透析患者长期使用促红细胞生成剂的治疗情况。
PLoS One. 2016 Mar 15;11(3):e0151601. doi: 10.1371/journal.pone.0151601. eCollection 2016.
3
Suppression of plasma hepcidin by venesection during steady-state hypoxia.在稳定状态下缺氧期间通过放血抑制血浆铁调素
Blood. 2016 Mar 3;127(9):1206-7. doi: 10.1182/blood-2015-05-647404. Epub 2016 Jan 15.
4
Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.在β地中海贫血小鼠模型中，促红细胞生成素铁调素有助于抑制铁调素并导致铁过载。
Blood. 2015 Oct 22;126(17):2031-7. doi: 10.1182/blood-2015-07-658419. Epub 2015 Aug 14.
5
Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.血红蛋白H病与中间型β地中海贫血之间红细胞生成-铁调素-铁储存轴的差异。
Haematologica. 2015 May;100(5):e169-71. doi: 10.3324/haematol.2014.115733. Epub 2015 Jan 16.
6
Identification of erythroferrone as an erythroid regulator of iron metabolism.鉴定红系铁调素为铁代谢的红系调节因子。
Nat Genet. 2014 Jul;46(7):678-84. doi: 10.1038/ng.2996. Epub 2014 Jun 1.
Zotero 插件